Thomas Weichhart

8.6k total citations · 3 hit papers
83 papers, 5.9k citations indexed

About

Thomas Weichhart is a scholar working on Immunology, Molecular Biology and Physiology. According to data from OpenAlex, Thomas Weichhart has authored 83 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Immunology, 35 papers in Molecular Biology and 20 papers in Physiology. Recurrent topics in Thomas Weichhart's work include PI3K/AKT/mTOR signaling in cancer (18 papers), Mast cells and histamine (11 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers). Thomas Weichhart is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (18 papers), Mast cells and histamine (11 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers). Thomas Weichhart collaborates with scholars based in Austria, United States and Germany. Thomas Weichhart's co-authors include Marcus D. Säemann, Markus Hengstschläger, Monika Linke, Walter H. Hörl, Nyamdelger Sukhbaatar, Maximilian Zeyda, Michael Haidinger, Thomas M. Stulnig, Marko Poglitsch and Gerhard J. Zlabinger and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Blood.

In The Last Decade

Thomas Weichhart

82 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The TSC-mTOR Signaling Pathway Regulates the Innate Inflammatory Response

2008 655 citations Thomas Weichhart, Marko Poglitsch et al. Immunity profile →
Regulation of innate immune cell function by mTOR

2015 622 citations Thomas Weichhart, Markus Hengstschläger et al. Nature reviews. Immunology profile →
mTOR as Regulator of Lifespan, Aging, and Cellular Senescence: A Mini-Review

2017 393 citations Thomas Weichhart profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Weichhart Austria	38	2.1k	2.1k	994	883	598	83	5.9k
Juan Zhang China	39	3.2k 1.5×	2.5k 1.2×	610 0.6×	675 0.8×	520 0.9×	211	6.5k
Huabao Xiong China	46	2.4k 1.1×	3.3k 1.6×	699 0.7×	590 0.7×	945 1.6×	123	7.4k
Shruti Sharma United States	36	3.0k 1.4×	3.0k 1.4×	778 0.8×	617 0.7×	539 0.9×	140	6.3k
Amir S. Yazdi Germany	30	5.0k 2.4×	2.7k 1.3×	1.4k 1.4×	564 0.6×	726 1.2×	112	8.4k
Alejandro Zentella‐Dehesa Mexico	32	3.3k 1.6×	1.6k 0.8×	833 0.8×	498 0.6×	975 1.6×	140	6.7k
Inpyo Choi South Korea	46	4.5k 2.1×	2.8k 1.3×	935 0.9×	757 0.9×	1.1k 1.8×	133	8.0k
Jie Fan United States	52	3.6k 1.7×	2.2k 1.0×	1.2k 1.2×	674 0.8×	380 0.6×	148	7.4k
Tanya N. Mayadas United States	52	2.2k 1.0×	4.6k 2.2×	848 0.9×	647 0.7×	579 1.0×	80	8.9k
Martin Bilban Austria	49	4.8k 2.3×	2.1k 1.0×	839 0.8×	662 0.7×	966 1.6×	143	8.4k
Thorsten Berger Canada	32	2.6k 1.2×	1.2k 0.6×	763 0.8×	468 0.5×	776 1.3×	48	6.0k

Countries citing papers authored by Thomas Weichhart

Since Specialization

Citations

This map shows the geographic impact of Thomas Weichhart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Weichhart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Weichhart more than expected).

Fields of papers citing papers by Thomas Weichhart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Weichhart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Weichhart. The network helps show where Thomas Weichhart may publish in the future.

Co-authorship network of co-authors of Thomas Weichhart

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Weichhart. A scholar is included among the top collaborators of Thomas Weichhart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Weichhart. Thomas Weichhart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Granitzer, Sebastian, Isabella Ellinger, Harald Zeisler, et al.. (2025). LAT1-NRF2 axis controls sFlt-1/PlGF imbalance and oxidative stress in preeclampsia. Nature Communications. 16(1). 9112–9112.

Cai, Zhengnan, Li Wan, Sonja Hager, et al.. (2024). Targeting PHGDH reverses the immunosuppressive phenotype of tumor-associated macrophages through α-ketoglutarate and mTORC1 signaling. Cellular and Molecular Immunology. 21(5). 448–465. 38 indexed citations

Kumpitsch, Christina, et al.. (2024). Exploring the human archaeome: its relevance for health and disease, and its complex interplay with the human immune system. FEBS Journal. 292(6). 1316–1329. 8 indexed citations

Weichhart, Thomas, et al.. (2024). Leveraging macrophage metabolism for anticancer therapy: opportunities and pitfalls. Trends in Pharmacological Sciences. 45(4). 335–349. 13 indexed citations

Nussinov, Ruth, Thomas Weichhart, Zodwa Dlamini, et al.. (2024). Directions to overcome therapy resistance in cancer. Trends in Pharmacological Sciences. 45(6). 467–471. 7 indexed citations

Lim, Clarice X., Alexandre F. Carisey, Scott A. Ochsner, et al.. (2023). SHP2 promotes sarcoidosis severity by inhibiting SKP2-targeted ubiquitination of TBET in CD8 ⁺ T cells. Science Translational Medicine. 15(713). eade2581–eade2581. 3 indexed citations

Vogel, Andrea & Thomas Weichhart. (2023). Tissue-resident macrophages — early passengers or drivers in the tumor niche?. Current Opinion in Biotechnology. 83. 102984–102984. 8 indexed citations

Krausgruber, Thomas, Daniele Barreca, Konstantin Doberer, et al.. (2023). Single-cell and spatial transcriptomics reveal aberrant lymphoid developmental programs driving granuloma formation. Immunity. 56(2). 289–306.e7. 67 indexed citations

Pizzini, Alex, Magdalena Aichner, Ivan Tancevski, et al.. (2021). High expression of mTOR signaling in granulomatous lesions is not predictive for the clinical course of sarcoidosis. Respiratory Medicine. 177. 106294–106294. 11 indexed citations

10.

Vijayan, Vijith, Srikanth Karnati, Vannuruswamy Garikapati, et al.. (2017). A New Immunomodulatory Role for Peroxisomes in Macrophages Activated by the TLR4 Ligand Lipopolysaccharide. The Journal of Immunology. 198(6). 2414–2425. 47 indexed citations

11.

Fritsch, Stephanie Deborah & Thomas Weichhart. (2016). Effects of Interferons and Viruses on Metabolism. Frontiers in Immunology. 7. 630–630. 97 indexed citations

12.

Sukhbaatar, Nyamdelger, Markus Hengstschläger, & Thomas Weichhart. (2016). mTOR-Mediated Regulation of Dendritic Cell Differentiation and Function. Trends in Immunology. 37(11). 778–789. 88 indexed citations

13.

Weichhart, Thomas, Markus Hengstschläger, & Monika Linke. (2015). Regulation of innate immune cell function by mTOR. Nature reviews. Immunology. 15(10). 599–614. 622 indexed citations breakdown →

14.

Schütz, Birgit, Hà Phạm, Margit Rosner, et al.. (2014). mTORC1 Is Essential for Early Steps during Schwann Cell Differentiation of Amniotic Fluid Stem Cells and Regulates Lipogenic Gene Expression. PLoS ONE. 9(9). e107004–e107004. 13 indexed citations

15.

Kopecky, Chantal, Bernd Genser, Christiane Drechsler, et al.. (2014). Quantification of HDL Proteins, Cardiac Events, and Mortality in Patients with Type 2 Diabetes on Hemodialysis. Clinical Journal of the American Society of Nephrology. 10(2). 224–231. 48 indexed citations

16.

Haidinger, Michael, Johannes Werzowa, Renate Kain, et al.. (2013). Hereditary amyloidosis caused by R554L fibrinogen Aα-chain mutation in a Spanish family and review of the literature. Amyloid. 20(2). 72–79. 15 indexed citations

17.

Haidinger, Michael, Johannes Werzowa, Johannes Pleiner, et al.. (2010). A randomized, placebo-controlled, double-blind, prospective trial to evaluate the effect of vildagliptin in new-onset diabetes mellitus after kidney transplantation. Trials. 11(1). 91–91. 16 indexed citations

18.

Säemann, Marcus D., Marko Poglitsch, Chantal Kopecky, et al.. (2010). The versatility of HDL: a crucial anti‐inflammatory regulator. European Journal of Clinical Investigation. 40(12). 1131–1143. 77 indexed citations

19.

Bobacz, Klaus, Jochen G. Hofstaetter, C. D. Toma, et al.. (2007). Toll‐like receptors and chondrocytes: The lipopolysaccharide‐induced decrease in cartilage matrix synthesis is dependent on the presence of toll‐like receptor 4 and antagonized by bone morphogenetic protein 7. Arthritis & Rheumatism. 56(6). 1880–1893. 111 indexed citations

20.

Weichhart, Thomas, Gerhard J. Zlabinger, & Marcus D. Säemann. (2005). The multiple functions of Tamm–Horsfall protein in human health and disease: A mystery clears up. Wiener klinische Wochenschrift. 117(9-10). 316–322. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact